VITALHUB CORP (VHI.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:VHI - CA92847V5018 - Common Stock
9.43 CAD
+0.1 (+1.07%)
Taking everything into account, VHI scores 6 out of 10 in our fundamental rating. VHI was compared to 8 industry peers in the Health Care Technology industry. VHI gets an excellent profitability rating and is at the same time showing great financial health properties. VHI is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! With these ratings, VHI could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
VHI had positive earnings in the past year.
In the past year VHI had a positive cash flow from operations.
In multiple years VHI reported negative net income over the last 5 years.
Of the past 5 years VHI 4 years had a positive operating cash flow.
1.2 Ratios
The Return On Assets of VHI (0.76%) is better than 100.00% of its industry peers.
VHI has a Return On Equity of 1.08%. This is amongst the best in the industry. VHI outperforms 100.00% of its industry peers.
VHI's Return On Invested Capital of 2.86% is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for VHI is in line with the industry average of 2.86%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 1.08% | ||
| ROIC | 2.86% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of VHI (2.88%) is better than 100.00% of its industry peers.
Looking at the Operating Margin, with a value of 12.47%, VHI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
VHI's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 80.92%, VHI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of VHI has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.47% | ||
| PM (TTM) | 2.88% | ||
| GM | 80.92% |
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VHI is destroying value.
Compared to 1 year ago, VHI has more shares outstanding
VHI has more shares outstanding than it did 5 years ago.
VHI has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.94 indicates that VHI is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.94, VHI is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
VHI has a debt to FCF ratio of 0.13. This is a very positive value and a sign of high solvency as it would only need 0.13 years to pay back of all of its debts.
VHI has a better Debt to FCF ratio (0.13) than 87.50% of its industry peers.
VHI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
VHI has a better Debt to Equity ratio (0.00) than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.13 | ||
| Altman-Z | 3.94 |
ROIC/WACC0.32
WACC8.86%
2.3 Liquidity
VHI has a Current Ratio of 1.94. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Current ratio value of 1.94, VHI belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
A Quick Ratio of 1.94 indicates that VHI should not have too much problems paying its short term obligations.
VHI's Quick ratio of 1.94 is amongst the best of the industry. VHI outperforms 87.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 |
3. Growth
3.1 Past
The earnings per share for VHI have decreased strongly by -14.29% in the last year.
The Revenue has grown by 59.34% in the past year. This is a very strong growth!
Measured over the past years, VHI shows a very strong growth in Revenue. The Revenue has been growing by 46.32% on average per year.
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
3.2 Future
The Earnings Per Share is expected to grow by 82.03% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 27.30% on average over the next years. This is a very strong growth
EPS Next Y68.34%
EPS Next 2Y107.36%
EPS Next 3Y82.03%
EPS Next 5YN/A
Revenue Next Year53.3%
Revenue Next 2Y36.21%
Revenue Next 3Y27.3%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 157.17, the valuation of VHI can be described as expensive.
Based on the Price/Earnings ratio, VHI is valued cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of VHI to the average of the S&P500 Index (26.31), we can say VHI is valued expensively.
The Price/Forward Earnings ratio is 31.33, which means the current valuation is very expensive for VHI.
87.50% of the companies in the same industry are more expensive than VHI, based on the Price/Forward Earnings ratio.
VHI is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 36.56, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 157.17 | ||
| Fwd PE | 31.33 |
4.2 Price Multiples
VHI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VHI is cheaper than 100.00% of the companies in the same industry.
VHI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. VHI is cheaper than 87.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 48.85 | ||
| EV/EBITDA | 21.67 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates VHI does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of VHI may justify a higher PE ratio.
VHI's earnings are expected to grow with 82.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.3
PEG (5Y)N/A
EPS Next 2Y107.36%
EPS Next 3Y82.03%
5. Dividend
5.1 Amount
No dividends for VHI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:VHI (11/28/2025, 7:00:00 PM)
9.43
+0.1 (+1.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners28.48%
Inst Owner ChangeN/A
Ins Owners11.46%
Ins Owner ChangeN/A
Market Cap595.22M
Revenue(TTM)98.17M
Net Income(TTM)2.83M
Analysts81.33
Price Target15.51 (64.48%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-78.71%
Min EPS beat(2)-129.12%
Max EPS beat(2)-28.31%
EPS beat(4)0
Avg EPS beat(4)-61.43%
Min EPS beat(4)-129.12%
Max EPS beat(4)-28.31%
EPS beat(8)0
Avg EPS beat(8)-58.34%
EPS beat(12)1
Avg EPS beat(12)-46.79%
EPS beat(16)2
Avg EPS beat(16)-54.73%
Revenue beat(2)2
Avg Revenue beat(2)9.95%
Min Revenue beat(2)7.24%
Max Revenue beat(2)12.66%
Revenue beat(4)4
Avg Revenue beat(4)6.3%
Min Revenue beat(4)0.61%
Max Revenue beat(4)12.66%
Revenue beat(8)6
Avg Revenue beat(8)4.15%
Revenue beat(12)10
Avg Revenue beat(12)4.05%
Revenue beat(16)12
Avg Revenue beat(16)4.16%
PT rev (1m)-1.75%
PT rev (3m)-2.08%
EPS NQ rev (1m)-13.45%
EPS NQ rev (3m)-11.91%
EPS NY rev (1m)0.36%
EPS NY rev (3m)-12.77%
Revenue NQ rev (1m)3.96%
Revenue NQ rev (3m)4.75%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)3.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 157.17 | ||
| Fwd PE | 31.33 | ||
| P/S | 6.06 | ||
| P/FCF | 48.85 | ||
| P/OCF | 46.07 | ||
| P/B | 2.27 | ||
| P/tB | 12.09 | ||
| EV/EBITDA | 21.67 |
EPS(TTM)0.06
EY0.64%
EPS(NY)0.3
Fwd EY3.19%
FCF(TTM)0.19
FCFY2.05%
OCF(TTM)0.2
OCFY2.17%
SpS1.56
BVpS4.15
TBVpS0.78
PEG (NY)2.3
PEG (5Y)N/A
Graham Number2.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 1.08% | ||
| ROCE | 4.19% | ||
| ROIC | 2.86% | ||
| ROICexc | 4.95% | ||
| ROICexgc | N/A | ||
| OM | 12.47% | ||
| PM (TTM) | 2.88% | ||
| GM | 80.92% | ||
| FCFM | 12.41% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y132.1%
ROICexc growth 5YN/A
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
F-Score3
Asset Turnover0.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.13 | ||
| Debt/EBITDA | 0.05 | ||
| Cap/Depr | 7.67% | ||
| Cap/Sales | 0.75% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 59.17% | ||
| Profit Quality | 430.43% | ||
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 | ||
| Altman-Z | 3.94 |
F-Score3
WACC8.86%
ROIC/WACC0.32
Cap/Depr(3y)9.42%
Cap/Depr(5y)8.61%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)466.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
EPS Next Y68.34%
EPS Next 2Y107.36%
EPS Next 3Y82.03%
EPS Next 5YN/A
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
Revenue Next Year53.3%
Revenue Next 2Y36.21%
Revenue Next 3Y27.3%
Revenue Next 5YN/A
EBIT growth 1Y46.83%
EBIT growth 3Y217.15%
EBIT growth 5YN/A
EBIT Next Year69.12%
EBIT Next 3Y40.69%
EBIT Next 5YN/A
FCF growth 1Y-12.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.32%
OCF growth 3YN/A
OCF growth 5YN/A
VITALHUB CORP / VHI.CA FAQ
What is the fundamental rating for VHI stock?
ChartMill assigns a fundamental rating of 6 / 10 to VHI.CA.
Can you provide the valuation status for VITALHUB CORP?
ChartMill assigns a valuation rating of 6 / 10 to VITALHUB CORP (VHI.CA). This can be considered as Fairly Valued.
Can you provide the profitability details for VITALHUB CORP?
VITALHUB CORP (VHI.CA) has a profitability rating of 7 / 10.
What are the PE and PB ratios of VITALHUB CORP (VHI.CA) stock?
The Price/Earnings (PE) ratio for VITALHUB CORP (VHI.CA) is 157.17 and the Price/Book (PB) ratio is 2.27.